2017 President-Elect: Alexis A. Thompson, MD, MPH
Alexis A. Thompson, MD, MPH, is the head of the hematology section of the Division of Hematology Oncology Transplantation and Director of the Comprehensive Thalassemia Program at the Ann and Robert H. Lurie Children’s Hospital of Chicago, where she also serves as the A. Watson and Sarah Armour Endowed Chair for Childhood Cancer and Blood Disorders. Dr. Thompson is also Associate Director of Equity and Minority Health at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. She earned her medical degree from Tulane University School of Medicine. After completing her residency at the Children’s Hospital of Los Angeles, Dr. Thompson earned her Master of Public Health at the University of California – Los Angeles School of Public Health, followed by additional postgraduate training at the Children’s Hospital of Philadelphia. She is board-certified in Pediatric Hematology-Oncology.
Immediately prior to her election as ASH Vice President, Dr. Thompson served as an ASH councilor from 2010-2014. She is currently a member of the ASH Sickle Cell Task Force and a reviewer for ASH’s journal, Blood. Dr. Thompson has also served on the ASH Committee on Government Affairs, as a mentor for the Society’s Minority Medical Student Award Program for more than 10 years, and she has co-chaired the ASH Annual Meeting Education Program. In addition to her service to ASH, Dr. Thompson has served on the Board of Directors of the National Marrow Donor Program and on the U.S. Department of Health and Human Services Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children.
Dr. Thompson’s major fields of interest include sickle cell disease, thalassemia, transfusional iron overload, and stem cell transplantation for pediatric patients. Her research has focused on developmentally regulated genes in early hematopoiesis, and she is an investigator on NIH-funded multi-center clinical trials as well as her own institutional clinical studies. In addition to her academic endeavors, Dr. Thompson is interested in enhancing the trainee pipeline in hematology, particularly in non-malignant hematology, and fostering international collaborations in hematology in regions with unmet medical need.
Dr. Thompson has received several prestigious awards, including the Robert Wood Johnson Foundation Minority Medical Faculty Development Award as well as the Minority Scholar Award in Cancer Research from the American Association for Cancer Research.
back to top